DE eng

Search in the Catalogues and Directories

Page: 1 2
Hits 1 – 20 of 21

1
Studying depression through big data analytics on Twitter
In: TDX (Tesis Doctorals en Xarxa) (2021)
BASE
Show details
2
Tropomyosin autoantibodies associated with checkpoint inhibitor myositis
In: Research outputs 2014 to 2021 (2020)
BASE
Show details
3
Factors that influence adherence to treatment plans amongst people living with cardiovascular disease: A review of published qualitative research studies
In: Research outputs 2014 to 2021 (2020)
BASE
Show details
4
Clinical Controversy in Transplantation: Tacrolimus Versus Cyclosporine in Statin Drug Interactions
In: Pharmacy Practice Faculty Publications (2020)
BASE
Show details
5
Clinical Controversy in Transplantation: Tacrolimus Versus Cyclosporine in Statin Drug Interactions
In: Pharmacy Practice Faculty Publications (2020)
BASE
Show details
6
New Directions in Treatments Targeting Stroke Recovery.
In: Stroke, vol 49, iss 12 (2018)
BASE
Show details
7
Serine Protease Inhibitors in Ticks: An Overview of Their Role in Tick Biology and Tick-Borne Pathogen Transmission
In: ISSN: 2235-2988 ; Frontiers in Cellular and Infection Microbiology ; https://hal.sorbonne-universite.fr/hal-01536659 ; Frontiers in Cellular and Infection Microbiology, Frontiers, 2017, 7, pp.199. ⟨10.3389/fcimb.2017.00199⟩ (2017)
BASE
Show details
8
Avanafil - a further step to tailoring patient needs and expectations
L. Boeri; P. Capogrosso; E. Ventimiglia. - : Taylor & Francis, 2016
BASE
Show details
9
Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial
In: PMC (2013)
BASE
Show details
10
Emotional face recognition deficits and medication effects in pre-manifest through stage-II Huntington's disease.
In: Psychiatry Res , 207 (1-2) 118 - 126. (2013) (2013)
BASE
Show details
11
A Review of Potential Harmful Interactions between Anticoagulant/Antiplatelet Agents and Chinese Herbal Medicines
Tsai, Hsin-Hui; Lin, Hsiang-Wen; Lu, Ying-Hung. - : Public Library of Science, 2013
BASE
Show details
12
Guideline for the diagnosis and management of myelofibrosis.
In: Symplectic Elements at Oxford ; Europe PubMed Central ; PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) ; Web of Science (Lite) (http://apps.webofknowledge.com/summary.do) ; Scopus (http://www.scopus.com/home.url) ; CrossRef (2012)
BASE
Show details
13
Semantic memory and language dysfunction in early Alzheimer's disease: a review.
In: Int J Geriatr Psychiatry , 27 (12) pp. 1209-1217. (2012) (2012)
BASE
Show details
14
Cardiorenal end points in a trial of aliskiren for type 2 diabetes.
In: New England Journal of Medicine, vol. 367, no. 23, pp. 2204-2213 (2012)
BASE
Show details
15
Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers.
In: Symplectic Elements at Oxford ; Europe PubMed Central ; PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) ; Web of Science (Lite) (http://apps.webofknowledge.com/summary.do) ; Scopus (http://www.scopus.com/home.url) ; CrossRef (2009)
BASE
Show details
16
Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease.
In: Symplectic Elements at Oxford ; Europe PubMed Central ; PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) ; Web of Science (Lite) (http://apps.webofknowledge.com/summary.do) ; Scopus (http://www.scopus.com/home.url) ; CrossRef (2008)
BASE
Show details
17
Systematic review comparing meropenem with imipenem plus cilastatin in the treatment of severe infections.
In: Symplectic Elements at Oxford ; Europe PubMed Central ; PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) ; Web of Science (Lite) (http://apps.webofknowledge.com/summary.do) ; Scopus (http://www.scopus.com/home.url) ; CrossRef (2005)
Abstract: OBJECTIVE: To compare the effectiveness of meropenem with imipenem plus cilastatin in the treatment of severe infections. DATA SOURCES: CENTRAL, EMBASE and MEDLINE were searched for abstracts and papers. All searching was completed in March 2004. No restriction was placed on language. STUDY SELECTION: Randomized controlled trials of adult patients with severe infections treated with meropenem or imipenem plus cilastatin at an equal dose, on a gram-for-gram basis, and with the same dosing regimen. DATA EXTRACTION: Two reviewers independently assessed papers against the inclusion/exclusion criteria and for methodological quality with differences in opinion adjudicated by a third party. Data were extracted on clinical response, bacteriologic response, mortality and adverse events. DATA SYNTHESIS: A total of 27 trials met the inclusion criteria. Meta-analyses were carried out using a Fixed Effects model. Results demonstrated that when compared to imipenem plus cilastatin, meropenem is associated with a significantly greater clinical response (Relative Risk 1.04; 95% Confidence Interval: 1.01-1.06), a significantly greater bacteriologic response (RR 1.05; 95% CI: 1.01-1.08), a non-significant reduction in mortality (RR 0.98; 95% CI: 0.71-1.35), and a significantly lower adverse event rate (RR 0.87; 95% CI: 0.77-0.97). CONCLUSIONS: This systematic review demonstrates that meropenem compared to imipenem plus cilastatin has a significantly greater clinical and bacteriologic response with a significant reduction in adverse events. There was no evidence of heterogeneity or publication bias and the analyses were robust to changes in the inclusion/exclusion criteria and use of a Random Effects model.
Keyword: Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Combination; Drug Therapy; Humans; Imipenem; Protease Inhibitors; Randomized Controlled Trials as Topic; Risk; Thienamycins
URL: https://doi.org/10.1185/030079905x46223
BASE
Hide details
18
Applications in pharmacokinetic modeling
Arnold, Esther. - : uga, 2003
BASE
Show details
19
Letter to Carl E. Duncan from Farris Bryant. ( 1952-08-08 )
BASE
Show details
20
Mailing List for 1955 State Tournament. ( 1955-00-00 )
BASE
Show details

Page: 1 2

Catalogues
0
0
0
0
0
0
0
Bibliographies
0
0
0
0
0
0
0
0
0
Linked Open Data catalogues
0
Online resources
0
0
0
0
Open access documents
21
0
0
0
0
© 2013 - 2024 Lin|gu|is|tik | Imprint | Privacy Policy | Datenschutzeinstellungen ändern